Plasma α1,3-fucosyltransferase deficiency in schizophrenia

Experimental and Clinical Immunogenetics

Volumn 16, Issue 3, 1999, Pages 125-130

  Yazawa, Shin ^a   Tanaka, Susumu ^a   Nishimura, Toyo ^a   Miyanaga, Kazuo ^b   Kochibe, Naohisa ^c  

^a JAPAN IMMUNORESEARCH LABORATORIES   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

FUT6 gene; Lewis blood group; Plasma 1,3 fucosyltransferase; Schizophrenia

Indexed keywords

ENZYME INHIBITOR; FUCOSYLTRANSFERASE; GALACTOSIDE 3 FUCOSYLTRANSFERASE; GALACTOSIDE 3(4) LEVO FUCOSYLTRANSFERASE; GALACTOSIDE 3(4)-L-FUCOSYLTRANSFERASE; GALACTOSIDE 3-FUCOSYLTRANSFERASE;

ARTICLE; BLOOD GROUP LEWIS SYSTEM; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME DEFICIENCY; GENOTYPE; HUMAN; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; POINT MUTATION; PRIORITY JOURNAL; SCHIZOPHRENIA; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; ENZYMOLOGY; GENETICS; JAPAN;

CASE-CONTROL STUDIES; FUCOSYLTRANSFERASES; GENOTYPE; HUMANS; JAPAN; LEWIS BLOOD-GROUP SYSTEM; POINT MUTATION; SCHIZOPHRENIA;

EID: 0032587424     PISSN: 02549670     EISSN: None     Source Type: Journal    
DOI: 10.1159/000019104     Document Type: Article

References (21)

1. 1-acid glycoprotein. J Biol Chem 1996;271: 14492-14495.
2. Yazawa S, Madiyalakan R, Izawa H, Asao T, Furukawa K, Matta KL: Cancer-associated elevation of α(1→3)-L-fucosyltransferase activity in human serum. Cancer 1988;62: 516-520.
3. Greenwell P, Johnson PH, Edwards JM, Reed RM, Moores PP, Bird A, Graham HA, Watkins WM: Association of the human Lewis blood group Le(a-b-c-d-) with the failure of expression of alpha-3-L-fucosyltransferase. Rev Fr Transfus Immunohematol 1986;29:233-249.
4. Caillard T, Le Pendu J, Ventura M, Mada M, Rault G, Mannoni R, Orial R: Failure of expression of alpha-3-L-fucosyltransferase in human serum is coincident in the kidney but not on leucocytes. Exp Clin Immunogenet 1988;5:15-23.
5. Mollicone R, Reguigne I, Fletcher A, Aziz A, Rustam M, Weston BW, Kelly RJ, Lowe JB, Oriol R: Molecular basis for plasma α(1,3)fucosyltransferase gene deficiency (FUT6). J Biol Chem 1994;269:12662-12671.
6. Varma R, Hoshino AY, Vercellotti JR: Serum glycoproteins in schizophrenia. Carbohydr Res 1980;82: 343-351.
7. Brunngraber EG, Davis LG, Rieser C, Reddy MV: Urinary glycoconjugates in schizophrenic patients. Biol Psychiat 1981;16:741-751.
8. Maguire TM, Thakore J, Dinan TG, Hopwood S, Breen KC: Plasma sialyltransferase levels in psychiatric disorders as a possible indicator of HPA axis function. Biol Psychiatry 1997;41:1131-1136.
9. Mellshop GW, Koadlow L, Wittingham S: Absence of rheumatoid arthritis in schizophrenia. Aust N Z J Med 1974;4:247-252.
10. Eaton WW, Hayward C, Rana R: Schizophrenia and rheumatoid arthritis: A review. Schizophr Res 1992;6:181-192.
11. Yazawa S, Nakamura J, Asao T, Nagamachi Y, Sagi M, Matta KL, Tachikawa T, Akamatsu M: Aberrant α1→2fucosyltransferase found in human colorectal carcinoma involved in the accumulation of Leb and Y antigens in colorectal tumors. Jpn J Cancer Res 1993;84:989-995.
12. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
13. Borsig L, Katopodis AG, Bowen BR, Berger EG: Trafficking and localization studies of recombinant α1,3-fucosyltransferase VI stably expressed in CHO cells. Glycobiology 1998;8:259-268.
14. Nakamura J, Mogi A, Asao T, Nagamachi Y, Yazawa S: Evidence that the aberrant α1→2fucosyltransferase found in colorectal carcinoma may be encoded by Fuc-TIII (Le) gene. Anticancer Res 1997;17: 4563-4570.
15. Yazawa S, Nishihara S, Iwasaki H, Asao T, Nagamachi Y, Malta KL, Narimatsu H: Genetic and enzymatic evidence for Lewis enzyme expression in Lewis-negative cancer patients. Cancer Res 1995;55:1473-1478.
16. Nishihara S, Narimatsu H, Iwasaki H, Yazawa S, Akamatsu S, Ando T, Seno T, Narimatsu I: Molecular genetic analysis of the human Lewis histo-blood group system. J Biol Chem 1994;269:29271-29278.
17. Yazawa S, Oh-Kawara H, Nakajima T, Hosomi O, Akamatsu S, Kishi K: Histo-blood group Lewis genotyping from human hairs and blood. Jpn J Hum Genet 1996;41:177-188.
18. Reguigne-Arnould I, Couillin P, Mollicone R, Faure S, Fletcher A, Kelly RJ. Low JB, Oriol R: Relative positions of two clusters of human α-L-fucosyltransferases in 19q (FUT1-FUT2) and 19p (FUT6-FUT3-FUT5) within the microsatellite genetic map of chromosome 19. Cytogenet Cell Genet 1995;71:158-162.
19. Larson G, Börjeson C, Elmgren A, Kernholt A, Henry S, Fletcher A, Azia A, Mollicone R, Oriol R: Identification of a new plasma α(1,3)fucosyltransferase (FUT6) allele requires an extended genotyping strategy. Vox Sang 1996;71:233-241.
20. Chodirker BN, Chudley AE, Ray M, Wickstrom DE, Riordan DL: Fragile 19p13 in a family with mental illness. Clin Genet 1987;31:1-6.
21. Watkins WM: Biosynthesis 5. Molecular basis of antigenic specificity in the ABO, H and Lewis blood-group systems; in Montreuil J, Vliegenthart JFG, Schachter H (eds): Glycoproteins. Amsterdam, Elsevier Science, 1995, 29a, pp 313-390.